Convergent cross-species pro-cognitive effects of RGH-235, a new potent and selective histamine H3 receptor antagonist/inverse agonist.
Némethy Z, Kiss B, Lethbridge N, Chazot P, Hajnik T, Tóth A, Détári L, Schmidt É, Czurkó A, Kostyalik D, Oláh V, Hernádi I, Balázs O, Vizi ES, Ledneczki I, Mahó S, Román V, Lendvai B, Lévay G.
Némethy Z, et al. Among authors: vizi es.
Eur J Pharmacol. 2022 Feb 5;916:174621. doi: 10.1016/j.ejphar.2021.174621. Epub 2021 Dec 26.
Eur J Pharmacol. 2022.
PMID: 34965389